News2017-04-11T16:23:24+00:00

FDA Approves Seno Medical’s Ground-Breaking Breast Cancer Diagnostic Technology

January 19, 2021 - The Center for Devices and Radiological Health (CDRH) of the US Food & Drug Administration (FDA) has granted Texas-based Seno Medical Instruments, Inc. (Seno) premarket approval (PMA) for its groundbreaking diagnostic [...]

January 20th, 2021|
Go to Top